- 公司
公司
Model N supports the complex business needs of the world’s leading brands in pharmaceutical, medical device, high tech, manufacturing and semiconductors across more than 120 countries, including Pfizer, AstraZeneca, Sanofi, Gilead, Abbott, Stryker, AMD, Micron, Seagate, STMicroelectronics, NXP, Sesotec, and Southern States.
- 右块
- 公司
公司
Model N supports the complex business needs of the world’s leading brands in pharmaceutical, medical device, high tech, manufacturing and semiconductors across more than 120 countries, including Pfizer, AstraZeneca, Sanofi, Gilead, Abbott, Stryker, AMD, Micron, Seagate, STMicroelectronics, NXP, Sesotec, and Southern States.
- 右块
- 公司
公司
Model N supports the complex business needs of the world’s leading brands in pharmaceutical, medical device, high tech, manufacturing and semiconductors across more than 120 countries, including Pfizer, AstraZeneca, Sanofi, Gilead, Abbott, Stryker, AMD, Micron, Seagate, STMicroelectronics, NXP, Sesotec, and Southern States.
- 右块
在法规和政府处方药计划的指导原则在不断地演变。随着改变联邦和各州的计划往往以接近实时发生的，药品生产企业必须不断地评估对现有能力的新需求，以有效管理合规性和控制成本。
面对厂家的，什么是需要简化操作检查该电子书识别独特的挑战，管理纠纷，并保证程序的要求。它概述了如何提高三个政府计划方案的流程并提高效率：
- 医疗药品回扣计划
- 340B药品价格方案
- 医疗保障部d承保缺口
现在，三个新的方法来脚本级数据验证优化政府计划参与的结果。
学到更多。现在退房的电子书！
感谢您的关注。
点击这里下载电子书。
